Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,902
archived clinical trials in
Irritable Bowel Syndrome (IBS)

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated:  2/16/2017
University of Calgary
mi
from
Calgary,
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease
Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease: OCEANIA Study
Status: Enrolling
Updated: 2/16/2017
University of Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease
Status: Enrolling
Updated:  3/2/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease
Status: Enrolling
Updated: 3/2/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
SBI in Children With d-IBS
Double-Blind, Randomized Pilot Study Evaluating Oral Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) on Nutritional Status in Children With Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)
Status: Enrolling
Updated:  3/8/2017
Children's Hospital
mi
from
New Orleans, LA
SBI in Children With d-IBS
Double-Blind, Randomized Pilot Study Evaluating Oral Serum-Derived Bovine Immunoglobulin Protein Isolate (SBI) on Nutritional Status in Children With Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS)
Status: Enrolling
Updated: 3/8/2017
Children's Hospital
mi
from
New Orleans, LA
Click here to add this to my saved trials
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated:  4/25/2017
Boston Med Ctr
mi
from
Boston, MA
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients
Status: Enrolling
Updated: 4/25/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers
A Phase IIa Experimental Medicine Study Assessing Alterations in Regional Cerebral Blood Flow by Functional Magnetic Resonance Imaging (fMRI) in Female IBS Patients and Healthy Controls Following Single Doses of GW876008, a Corticotrophin Releasing Factor 1 Receptor Antagonist (CRF1-RA)
Status: Enrolling
Updated:  5/15/2017
GSK Investigational Site
mi
from
Los Angeles, CA
Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy Volunteers
A Phase IIa Experimental Medicine Study Assessing Alterations in Regional Cerebral Blood Flow by Functional Magnetic Resonance Imaging (fMRI) in Female IBS Patients and Healthy Controls Following Single Doses of GW876008, a Corticotrophin Releasing Factor 1 Receptor Antagonist (CRF1-RA)
Status: Enrolling
Updated: 5/15/2017
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Status: Enrolling
Updated:  5/16/2017
University of Maryland
mi
from
Baltimore, MD
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
Status: Enrolling
Updated: 5/16/2017
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status: Enrolling
Updated:  5/22/2017
Presbyterian University Hospital of UPMC
mi
from
Pittsburgh, PA
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status: Enrolling
Updated: 5/22/2017
Presbyterian University Hospital of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status: Enrolling
Updated:  5/22/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status: Enrolling
Updated: 5/22/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study Comparing Rifaximin With Xifaxan 200mg in Traveler's Diarrhea
A Randomized, Double-Blind, Parallel, Multicenter, Bioequivalence Study Comparing Rifaximin 200-mg Tablets With Xifaxan® 200-mg Tablets and With Placebo in the Treatment of Traveler's Diarrhea
Status: Enrolling
Updated:  6/26/2017
Clinical Research Facility
mi
from
Coral Gables, FL
Study Comparing Rifaximin With Xifaxan 200mg in Traveler's Diarrhea
A Randomized, Double-Blind, Parallel, Multicenter, Bioequivalence Study Comparing Rifaximin 200-mg Tablets With Xifaxan® 200-mg Tablets and With Placebo in the Treatment of Traveler's Diarrhea
Status: Enrolling
Updated: 6/26/2017
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Mobile Self-Management of Irritable Bowel Syndrome for Adolescents
Mobile Self-Management of Irritable Bowel Syndrome for Adolescents: Pilot Study
Status: Enrolling
Updated:  6/26/2017
UCLA Pediatric Pain Program Research Offices
mi
from
Los Angeles, CA
Mobile Self-Management of Irritable Bowel Syndrome for Adolescents
Mobile Self-Management of Irritable Bowel Syndrome for Adolescents: Pilot Study
Status: Enrolling
Updated: 6/26/2017
UCLA Pediatric Pain Program Research Offices
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clotrimazole Enemas for Pouchitis in Children and Adults
Clotrimazole Enemas for Pouchitis in Children and Adults
Status: Enrolling
Updated:  7/18/2017
Boston Children's Hospital
mi
from
Boston, MA
Clotrimazole Enemas for Pouchitis in Children and Adults
Clotrimazole Enemas for Pouchitis in Children and Adults
Status: Enrolling
Updated: 7/18/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated:  7/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated:  7/18/2017
BeHealth Solutions, LLC
mi
from
Charlottesville, VA
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
BeHealth Solutions, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Individualized Infiximab Dosing-Proof of Concept Study
Individualized Infiximab Dosing-Proof of Concept Study
Status: Enrolling
Updated:  7/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Individualized Infiximab Dosing-Proof of Concept Study
Individualized Infiximab Dosing-Proof of Concept Study
Status: Enrolling
Updated: 7/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients
Status: Enrolling
Updated:  7/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients
Status: Enrolling
Updated: 7/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
Status: Enrolling
Updated:  8/1/2017
Children's Nutrition Research Center
mi
from
Houston, TX
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
Status: Enrolling
Updated: 8/1/2017
Children's Nutrition Research Center
mi
from
Houston, TX
Click here to add this to my saved trials
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
Status: Enrolling
Updated:  8/1/2017
Texas Children's Hospital
mi
from
Houston, TX
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
Delivered Dietary Intervention for Children With Irritable Bowel Syndrome
Status: Enrolling
Updated: 8/1/2017
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
The Effect of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome: A Prospective Pilot Study
Status: Enrolling
Updated:  9/13/2017
UNC Center for Functional GI and Motility Disorders
mi
from
Chapel Hill, NC
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
The Effect of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome: A Prospective Pilot Study
Status: Enrolling
Updated: 9/13/2017
UNC Center for Functional GI and Motility Disorders
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study
Safety and Immunogenicity Evaluation of an Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) in Volunteers
Status: Enrolling
Updated:  9/25/2017
Walter Reed Army Institute for Research
mi
from
Silver Spring, MD
Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) Dose-Ranging Study
Safety and Immunogenicity Evaluation of an Intranasal Recombinant Flagellin Subunit Campylobacter Vaccine (rFla-MBP) in Volunteers
Status: Enrolling
Updated: 9/25/2017
Walter Reed Army Institute for Research
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
Self Administered CBT for IBS: A Multisite Trial
Status: Enrolling
Updated:  10/3/2017
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
Self Administered CBT for IBS: A Multisite Trial
Status: Enrolling
Updated: 10/3/2017
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
Self Administered CBT for IBS: A Multisite Trial
Status: Enrolling
Updated:  10/3/2017
University at Buffalo School of Medicine
mi
from
Buffalo, NY
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
Self Administered CBT for IBS: A Multisite Trial
Status: Enrolling
Updated: 10/3/2017
University at Buffalo School of Medicine
mi
from
Buffalo, NY
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Athens, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Athens, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Birmingham, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Dothan, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Dothan, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Foley, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Foley, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Huntsville, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Montgomery, AL
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Montgomery, AL
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Chandler, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Chandler, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Glendale, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Phoenix, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Tucson, AZ
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Conway, AR
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Conway, AR
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Little Rock, AR
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Little Rock, AR
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Anaheim, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Artesia, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Artesia, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Chula Vista, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Corona, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Corona, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Encino, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Encino, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Fountain Valley, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Fresno, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Fresno, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Garden Grove, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
La Mesa, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
La Mesa, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
La Mirada, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
La Mirada, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Laguna Hills, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Lancaster, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Lancaster, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
North Hollywood, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
North Hollywood, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
Sacramento, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
San Bernardino, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
San Bernardino, CA
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated:  10/3/2017
Synergy Research Site
mi
from
San Diego, CA
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Synergy Research Site
mi
from
San Diego, CA
Click here to add this to my saved trials